Vol. 1, Ed. 22 — Sat Sep 5: New Mexico tracking rollout losses mount, suit resets

New Mexico retailers report six-figure losses after the state's tracking-system cutover as the industry's court challenge resets; FDA opens a 60-day botanical drug comment period; Missouri recalls products over modified cannabinoids. For general information only — not legal advice.

What is NRBC Compliance Brief?

The NRBC Compliance Brief is a daily two-minute audio briefing on U.S. alcohol and hemp/THC regulation, covering federal agencies and all 50 states: TTB rulings and rulemaking, state alcohol authority actions, the federal hemp-ban timeline, THC-beverage rules, court decisions, taxes, tariffs, licensing, and enforcement. A new episode arrives every morning around 7 AM Eastern.

Produced by the compliance desk at New Realm Brewing Co. and narrated with AI assistance under the direction of CFO Jeremy Barnes. Strictly factual and neutral: what passed, what was signed, what a court held, and the dates that matter — with every position attributed to the person or group who took it. For general information only — not legal advice.

Want the full written brief with source links in your inbox each morning? Email [e-mail] with the subject "Subscribe - Compliance Brief"

This is the New Realm Compliance Brief, Volume 1, Edition 22, for Saturday, September 5.

Our top story: New Mexico's cannabis industry completed its switch to the state's new seed-to-sale tracking system this week, and retailers say the first days have been costly. One operator reported four hundred sixty thousand dollars of inventory miscategorized in the new system, another said roughly fifty thousand items failed to transfer, and businesses described hiring extra staff just to correct errors. The head of the Cannabis Association of New Mexico, Matt Kennicott, said parts of the system are missing or unrealistic for operations, and warned that manual tax calculations create legal risk. The association temporarily withdrew its emergency court challenge and said it plans to refile next week with documented financial damages.

At the federal level, the Food and Drug Administration opened a sixty day comment period on how it regulates botanical drug products, meaning medicines derived from plants, algae, or fungi. The agency is asking for input on research barriers, quality standards, and study design. Comments are due November third.

Around the states: Missouri's Division of Cannabis Regulation announced a recall of marijuana products containing chemically modified or synthetically derived cannabinoids. And in Idaho, voters this November will decide a constitutional amendment that would give the state legislature sole authority to legalize marijuana or other psychoactive substances, ending the citizen initiative route. Republican Senator Scott Grow urged approval, citing addiction concerns, while a competing medical cannabis campaign is challenging the state's handling of its own initiative.

On the radar: the federal hemp product ban, delayed by the funding bill signed this week, is now set to take effect December eleventh. And New Mexico's refiled tracking system challenge is expected in court next week.

Full details and source links are in today's email. This update is for general information only — it is not legal advice.